The FDA’s new guidance notes that an Oct.
22 meeting of its Vaccines and Related Biological Products Advisory Committee will not be to discuss specific vaccine candidates.
Story: https://wfts.tv/3jFXr3F
The FDA’s new guidance notes that an Oct.
22 meeting of its Vaccines and Related Biological Products Advisory Committee will not be to discuss specific vaccine candidates.
Story: https://wfts.tv/3jFXr3F
Right now, there is no FDA-approved vaccine for COVID-19, but researchers are racing to create one.
Pfizer is the first company to say it will start enrolling kids as young as 12 in its U.S. coronavirus vaccine trial. It says it..